Rchr
J-GLOBAL ID:201301023293235571   Update date: Mar. 07, 2024

Morishita Soji

モリシタ ソウジ | Morishita Soji
Affiliation and department:
Research field  (1): Hematology and oncology
Research keywords  (4): next generation sequencer ,  myeloproliferative neoplasms ,  gene markers ,  genetic testing
Research theme for competitive and other funds  (7):
  • 2020 - 2023 本態性血小板血症に特異的な転写ネットワークによる細胞腫瘍化メカニズムの解明
  • 2017 - 2020 Clarification of the pathogenesis of myeloproliferative neoplasms based on the identification of genetic factors in familial cases
  • 2016 - 2019 Elucidation of molecular mechanism of cytokie receptor activation by mutant CALR
  • 2016 - 2019 Finding poor prognostic factors of myelofibrosis targeting tumor cell population
  • 2015 - 2018 Identification of promising marker(s) for essential thrombocythemia diagnosis by differential gene expression approach
Show all
Papers (73):
  • Satoshi Yamazaki, Yo Mabuchi, Takaharu Kimura, Eriko Grace Suto, Daisuke Hisamatsu, Yuna Naraoka, Ayako Kondo, Yuzuki Azuma, Riko Kikuchi, Hidekazu Nishikii, et al. Activated mesenchymal stem/stromal cells promote myeloid cell differentiation via CCL2/CCR2 signaling. Stem cell reports. 2024
  • Chiho Furuya, Yoshinori Hashimoto, Soji Morishita, Tadaaki Inano, Tomonori Ochiai, Shuichi Shirane, Yoko Edahiro, Marito Araki, Miki Ando, Norio Komatsu. MPL gene mutation is a possible risk factor for thrombosis in patients with essential thrombocythemia in Japan. Hematology (Amsterdam, Netherlands). 2023. 28. 1. 2229131-2229131
  • Yoko Edahiro, Tomonori Ochiai, Yoshinori Hashimoto, Soji Morishita, Shuichi Shirane, Tadaaki Inano, Chiho Furuya, Michiaki Koike, Masaaki Noguchi, Kensuke Usuki, et al. Clinical characteristics of Japanese patients with myelodysplastic/myeloproliferative neoplasm with ring sideroblasts and thrombocytosis. International journal of hematology. 2023. 118. 1. 47-53
  • Chang Liu, Misa Imai, Yoko Edahiro, Shuichi Mano, Hiraku Takei, Mai Nudejima, Akira Kurose, Soji Morishita, Miki Ando, Satoshi Tsuneda, et al. Establishment of isogenic induced pluripotent stem cells with or without pathogenic mutation for understanding the pathogenesis of myeloproliferative neoplasms. Experimental Hematology. 2023. 118. 12-20
  • Chiho Furuya, Yoshinori Hashimoto, Soji Morishita, Tadaaki Inano, Tomonori Ochiai, Shuichi Shirane, Yoko Edahiro, Marito Araki, Miki Ando, Norio Komatsu. Reevaluation of cardiovascular risk factors for thrombotic events in 580 Japanese patients with essential thrombocythemia. JOURNAL OF THROMBOSIS AND THROMBOLYSIS. 2022
more...
MISC (36):
  • 森下総司, 小松則夫. JAK2遺伝子検査が保険適用に. Medical Technology. 2020. 48. 12. 1226-1227
  • 森下総司, 安田肇, 山脇紗耶, 川路英哉, 伊藤昌可, 枝廣陽子, 今井美沙, 向後泰司, 常田聡, 大坂顯通, et al. 骨髄増殖性腫瘍の新規汎用診断マーカー. 日本血液学会学術集会抄録(Web). 2020. 82nd
  • 荒木 真理人, 森下 総司, 小松 則夫. 【造血器腫瘍の遺伝子異常】骨髄増殖性腫瘍の遺伝子異常. 臨床検査. 2019. 63. 7. 790-796
  • 枝廣 陽子, 竹井 拓, Liu Chang, ぬで島 麻衣, 森下 総司, 大坂 顯通, 荒木 真理人, 小松 則夫. ヒト造血幹細胞分化に対するJAK2V617Fアレルの負荷の影響(The impact of allelic burden of JAK2V617F on human hematopoietic cell differentiation). Cytometry Research. 2019. 29. Suppl. 68-68
  • 角南 義孝, 荒木 真理人, 山本 誠司, 白根 脩一, 堀内 祥行, 辻岡 一也, 茂櫛 薫, 山口 茂夫, 今井 美沙, 森下 総司, et al. 全トランス型レチノイン酸による白血病細胞分化制御因子の同定. Cytometry Research. 2019. 29. Suppl. 76-76
more...
Patents (5):
Professional career (1):
  • 博士(工学) (早稲田大学)
Awards (1):
  • 2019/11 - 第56回ベルツ賞2等賞 骨髄増殖性腫瘍の診断と治療の進歩
Association Membership(s) (1):
Japanese Society of Hematology
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page